Alaunos Therapeutics, Inc. (TCRT) Ownership
TCRT ownership summary
as of October 17, 2026- Institutions
- 23.2% of shares outstanding
- Insiders
- 12.41% of shares outstanding
- Shares outstanding
- 2.9M
- Float
- 1.9M shares available to trade
- Short interest
- 0.36% 9,736 shares short
- Days to cover
- — short interest up 60.3% vs prior month
- Institutions 23.25%
- Insiders 12.41%
- Other investors 64.34%
TCRT top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 0.73% | 21K | $56,158 | — | June 30, 2026 |
| 2 | Geode Capital Management, LLC | 0.66% | 19K | $50,906 | −3,204 (−14.2%) | June 30, 2026 |
| 3 | Vanguard Fiduciary Trust Co | 0.53% | 15K | $40,757 | — | June 30, 2026 |
| 4 | Vanguard Capital Management, LLC | 0.48% | 14K | $36,986 | — | June 30, 2026 |
| 5 | Citadel Advisors Llc | 0.41% | 12K | $31,218 | +1,351 (+12.8%) | June 30, 2026 |
| 6 | Advisor Group Holdings, Inc. | 0.06% | 1,731 | $4,553 | −48 (−2.7%) | June 30, 2026 |
| 7 | Tower Research Capital LLC | 0.06% | 1,621 | $4,263 | +38 (+2.4%) | June 30, 2026 |
| 8 | SRS Capital Advisors Inc | 0.04% | 1,216 | $3,198 | +1,216 (0.0%) | June 30, 2026 |
| 9 | UBS Group AG | 0.03% | 992 | $2,609 | −1,282 (−56.4%) | June 30, 2026 |
| 10 | Morgan Stanley - Brokerage Accounts | 0.03% | 836 | $2,199 | +183 (+28.0%) | June 30, 2026 |
| 11 | Vanguard Global Advisers, LLC | 0.02% | 501 | $1,318 | — | June 30, 2026 |
| 12 | Wells Fargo & Co | 0.01% | 388 | $1,020 | +198 (+104.2%) | June 30, 2026 |
| 13 | Royal Bank of Canada | 0.01% | 375 | $986 | +190 (+102.7%) | June 30, 2026 |
| 14 | Ronald Blue Trust, Inc. | <0.01% | 135 | $355 | — | June 30, 2026 |
| 15 | Steward Partners Investment Advisory, LLC | <0.01% | 112 | $295 | +20 (+21.7%) | June 30, 2026 |
| 16 | Federation des caisses Desjardins du Quebec | <0.01% | 70 | $184 | — | June 30, 2026 |
| 17 | Bank of Oklahoma National Association | <0.01% | 66 | $174 | +66 (0.0%) | June 30, 2026 |
| 18 | Axiom Investment Management LLC | <0.01% | 46 | $121 | +46 (0.0%) | June 30, 2026 |
| 19 | Mercer Global Advisors Inc. | <0.01% | 38 | $100 | +38 (0.0%) | June 30, 2026 |
| 20 | KEY Financial, INC. | <0.01% | 24 | $63 | — | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 3,346 shares and 3 cut 4,534.
TCRT top mutual fund and ETF holders
5 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.41% | 12K | $31,844 | −65 (−0.5%) | August 31, 2026 |
| 2 | Fidelity Total Market Index | 0.08% | 2,376 | $6,249 | — | August 31, 2026 |
| 3 | Fidelity Series Total Market Index | 0.08% | 2,317 | $6,094 | — | August 31, 2026 |
| 4 | Fidelity Nasdaq Composite Index | 0.04% | 1,117 | $2,938 | — | August 31, 2026 |
| 5 | Vanguard U.S. Eq Idx £ Acc | 0.02% | 501 | $1,318 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
TCRT insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-01 | Kevin S Sr. Boyle | Sell | $21.00 | 453 | $9,513 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
TCRT shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns TCRT
Institutional investors own 23.2% of Alaunos Therapeutics's shares and insiders 12.41%. The largest holder is BlackRock Inc with 0.73% of the shares (21K), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 3 reduced their stake in the latest filings. Short interest is 0.36% of the float. The share count rose 184.1% since 2014.
Related: TCRT key metrics. See the TCRT stock overview for the latest quote and news.
TCRT ownership FAQ
Who owns the most Alaunos Therapeutics stock?
The largest shareholders of Alaunos Therapeutics are BlackRock Inc (0.73%), Geode Capital Management, LLC (0.66%), Vanguard Fiduciary Trust Co (0.53%), Vanguard Capital Management, LLC (0.48%), Citadel Advisors Llc (0.41%).
What percentage of Alaunos Therapeutics is owned by institutions?
Institutions hold 23.2% of Alaunos Therapeutics's shares outstanding; insiders hold 12.41%.
Which funds own Alaunos Therapeutics?
The largest fund holders of Alaunos Therapeutics are Fidelity Extended Market Index (0.41%), Fidelity Total Market Index (0.08%), Fidelity Series Total Market Index (0.08%), Fidelity Nasdaq Composite Index (0.04%), Vanguard U.S. Eq Idx £ Acc (0.02%).
What is Alaunos Therapeutics's short interest?
9,736 shares of Alaunos Therapeutics were sold short, 0.36% of the float.
Are insiders buying or selling Alaunos Therapeutics?
Of the latest 1 reported insider transactions in Alaunos Therapeutics (since September 1, 2023), 0 were purchases and 1 were sales.
How many shares of Alaunos Therapeutics are outstanding?
Alaunos Therapeutics has 2.9M shares outstanding, of which 1.9M are in the public float.